Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Aurobindo Pharma Ltd.
12 Aug 2022
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Audio Recording Of Earnings Call Conducted On August 12, 2022
BSE India
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 8, 2022, please note that the audio recording of the earnings call on the unaudited financial results for the first quarter ended June 30, 2022, held on August 12, 2022, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/wp-content/uploads/2022/08/audio1190421139.mp3
pdf
logo
Aurobindo Pharma Ltd.
06 Jun 2022
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ Analysts call on May 31, 2022. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2022 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
31 May 2022
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Audio Recording Of Earnings Call
BSE India
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 26, 2022, please note that the audio recording of the earnings call for the fourth quarter and financial year ended March 31, 2022, held on May 31, 2022, at 8.30 AM (IST) has been uploaded on our website on the following web-link: https://www.aurobindo.com/wp-content/uploads/2022/05/Aurobindo-Q4-.mp3
pdf
logo
Aurobindo Pharma Ltd.
31 May 2022
1220.10
-3.00%
Conference Call with Aurobindo Pharma Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Aurobindo Pharma Ltd.
17 Feb 2022
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated February 3, 2022 wherein we have intimated the schedule of Investors/ Analysts call on February 10, 2022. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
10 Feb 2022
1220.10
-3.00%
Earnings Call for Q3FY22 of Aurobindo Pharma
Conference Call with Aurobindo Pharma Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Aurobindo Pharma Ltd.
19 Nov 2021
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated November 2, 2021 wherein we have intimated the schedule of Investors/ Analysts call on November 9, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
09 Nov 2021
1220.10
-3.00%
Conference Call with Aurobindo Pharma Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Aurobindo Pharma Ltd.
25 Aug 2021
1220.10
-3.00%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated August 7, 2021 wherein we have intimated the schedule of Investors/ Analysts call on August 13, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the first quarter ended June 30, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
13 Aug 2021
1220.10
-3.00%
Earnings Call for Q1FY22 of Aurobindo Pharma
Conference Call with Aurobindo Pharma Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.
video
 

Earnings Calls Podcast on